Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer

In epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), acquired resistance to EGFR tyrosine kinase inhibitors (TKI) leads to disease progression. Strategies to overcome the resistance are required in treatment for advanced lung cancer. In this study, we investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Si Yeon, Park, Ji Hye, Park, So-Jung, Kang, In-Cheol, Yoo, Hwa-Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793066/
https://www.ncbi.nlm.nih.gov/pubmed/36565160
http://dx.doi.org/10.1177/15347354221144311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793066/
https://www.ncbi.nlm.nih.gov/pubmed/36565160
http://dx.doi.org/10.1177/15347354221144311

Ejemplares similares